Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalomid in Chronic Pancreatitis
NCT00469703Phase 2Terminated
- Sponsor
- NYU Langone Hospital – Long Island
- Start
- Aug 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of thalidomide in chronic pancreatitis (CP), sponsored by NYU Langone Hospital – Long Island. Primary endpoints: Safety and Efficacy. Started Aug 2005; status: terminated.
02
Drugs
thalidomide
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT00469703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469703.